中文

Increase the probability
of your products' success

Words from the Founder

Words from the Founder

The global pharmaceutical industry is in the era of innovation filled with exciting opportunities. dMed, a Next Generation CRO, is well positioned to take advantage of these shifts in the global pharma industry by being the bridge between two of the world's largest pharmaceutical markets, the US and China. dMed operates at the highest international clinical standards and brings together the strengths and opportunities inherent in these markets.


dMed partners at all stages of the conception, design, and execution of clinical trials for new drug development. dMed has gathered a talented and experienced team of industry experts to help drug developers accelerate progress and improve their success rates.


Dr. Lingshi Tan, Chairman & CEO

China:
298 Xiangke Road, 3/F, 301-305, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201210, China
Tel: +86 21 5090 0085 Fax: +86 21 6875 5515
US:
261 Madison Avenue, 24th fl. New York, NY 10016 US
Phone: +1-212-681-2100
沪ICP备16041651号 Copyright © 2016 dMed All Rights Reserved
沪公网安备 31011502005403号